Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Texas Retina Center is a specialized medical practice focused on the diagnosis and treatment of vitreoretinal diseases. Led by Dr. Li-Heui (Lily) Tseng, the center provides advanced care for conditions such as age-related macular degeneration, diabetic retinopathy, and retinal detachments. The facility offers a range of diagnostic and therapeutic services, including intravitreal injections of anti-VEGF agents, retinal laser surgery, and complex vitreoretinal surgical procedures. Based in the Greater Houston area, the center serves as a clinical hub for patients requiring expert management of sight-threatening posterior segment eye disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Texas Retina Center.